2023-09-04 19:00:58
This condition is classified into three categories: non-serious, with warning signs and symptoms, and severe.
According to Cofepris, any dengue vaccine must always be given under medical evaluation and supervision.
During the first semester of 2023, the cases of this viral infection in Mexico exceeded those registered in the same period of the previous year.
Given some recent events, the Federal Commission for the Protection against Sanitary Risks (Cofepris) published an alert for a dengue vaccine that was wrongly applied to children. Due to what happened, the cooperation of all health professionals is requested so that this case does not repeat itself.
What happened?
According to what was reported, it was identified that the biological Dengvaxia developed by the pharmaceutical Sanofi It was applied to children under nine years of age. Based on this case, the highest health authority in the country requested the collaboration of all general practitioners, nursing staff and pediatricians so that it does not happen again.
Based on the Risk Notice on the use of the quadrivalent dengue vaccine published by Cofepristhe biological Dengvaxia It is indicated only for the population from nine years of age and up to 45 years of age.
Cofepris urges health professionals that, prior to applying this biological, they must verify that the packaging is in Spanish, has a health registry, lot number, and expiration date.
Likewise, these last data must coincide with those recorded in the vial with the lyophilized powder. In addition, it is suggested that medical personnel consult the attached instructions inside the package and review the Dengvaxia technical sheet.
In addition, cofepris He urged health personnel and the general population not to purchase medicines on social networks, sales platforms, or other internet sites, as it could be a counterfeit product made with contaminated, poor-quality ingredients and lacking the active ingredient.
Current situation of dengue in Mexico
On the other hand, it is necessary to remember that Mexico is listed as the second country with the most cases of dengue in Latin America, just below Brazil.
So far in 2023, the cases in Mexico have already exceeded the number of infections in the same period last year. Until August 7, 2023 (week 31), 8,291 cases of this disease were confirmed, while in the same period of 2022 the figure reached 2,704.
73% of the confirmed cases in 2023 correspond to five states: Quintana Roo, Veracruz, Yucatán Puebla and Morelos.4 This figure is similar to that reported in the same week of 2019, when the last dengue epidemic occurred in the country .
Types of dengue that exist
This condition is classified into three categories: non-serious, with warning signs and symptoms, and severe.
The first consists of the aforementioned signs accompanied by nausea and vomiting; the second is characterized by bleeding from the nose and gums, known as gingivorrhagia, as well as abdominal pain; in the third, hypobulemic shock usually occurs due to severe bleeding and organs such as the liver and kidneys are affected, although in very few cases it can endanger life.
Also read:
Dengue: Main symptoms and ways to prevent infections
Dengue in Mexico: What to do and what not to do against the disease
Mexico is the second country with the most cases of dengue in Latin America
#Cofepris #alerts #dengue #vaccine #applied #children